← All stocks

Cboe Global Markets

CBOE No buying or selling
CIK 0001374310 #94 in the set updated 18 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

24 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Isaacson Christopher A
EVP, COO
50,059
$13.96M
+25.2%
Tomczyk Fredric J
Director
35,631
$9.94M
+162.0%
Sexton John P
EVP, GC AND CORP SEC
29,575
$8.25M
+78.5%
PALMORE RODERICK A
Director
27,730
$7.74M
+4.8%
Griebenow Jill
EVP, CFO
17,081
$4.76M
+93.1%
Fitzpatrick Edward J.
Director
13,451
$3.75M
−16.7%
Froetscher Janet P
Director
12,870
$3.59M
−6.5%
Farrow William M III
Director
12,735
$3.55M
+11.0%
Goodman Jill R
Director
12,448
$3.47M
−10.3%
Parisi James E.
Director
9,969
$2.78M
+14.5%
Howson Dave
EVP, GLOBAL PRESIDENT
8,025
$2.24M
+6.0%
Fong Ivan K
Director
7,441
$2.08M
+20.4%
McPeek Jennifer J
Director
6,368
$1.78M
+24.6%
Matturri Alexander JR
Director
4,761
$1.33M
−13.9%
Foley Stephanie
EVP, CHRO
3,868
$1.08M
+371.1%
Lipscomb Timothy
EVP, Chief Technology Officer
2,638
$735.87K
+188.3%
DONOHUE CRAIG S
CEO
2,604
$726.39K
Mao Cecilia
Director
2,441
$680.92K
+106.5%
Mansfield Erin
Director
2,441
$680.92K
+106.5%
Clay Catherine R
EVP, GLOBAL DERIVATIVES
2,183
$608.95K
−49.6%
Inzirillo Adam
EVP, DATA VANTAGE
1,993
$555.95K
+50.6%
Hocking Robert A
EVP, Global Head of Derivs.
514
$143.38K
+82.3%
Wilkinson Allen
SVP, CHIEF ACCOUNTING OFFICER
410
$114.37K
+394.0%
Bhatia Prashant
EVP, Strategy & Corp Dev
95
$26.50K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 14 Sep 2016